Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa
Status:
Withdrawn
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Hidradenitis Suppurativa (HS), is a chronic skin disease, manifested as inflamed areas of
hair follicles around apocrine sweat glands found in areas most commonly the axillae,
inguinal and anogenital regions. Patients experience great deal of physical pain as well as
profound psychological problems. HS patients may also be prone to health complications and
diseases. Treatment to date is limited and consist mainly of antibiotic administration and
novel biological drug with up to 40% efficiency. Recently it was shown that cannabinoids
reduces the folliculo pilosebaceous activity, most likely due to activating arachnoiditis,
lipostat , anti-proliferative and anti-inflammatory agents and reduce inflammation inducing
cytokines.